23andMe Holding Co. (ME)
USD 3.14
(-3.09%)
USD 3.14
(-3.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 99.37 Million USD | -26.11% |
| 2022 | 134.49 Million USD | 1.17% |
| 2021 | 132.94 Million USD | 13.62% |
| 2020 | 117 Million USD | -14.86% |
| 2019 | 137.43 Million USD | -24.9% |
| 2018 | 182.98 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 14.72 Million USD | -45.51% |
| 2023 Q4 | 27.03 Million USD | 35.59% |
| 2023 Q2 | 21.72 Million USD | -29.18% |
| 2023 FY | 99.37 Million USD | -26.11% |
| 2023 Q3 | 19.93 Million USD | -8.25% |
| 2023 Q1 | 30.68 Million USD | -23.27% |
| 2022 Q4 | 39.98 Million USD | 30.02% |
| 2022 Q3 | 30.75 Million USD | -19.65% |
| 2022 Q2 | 38.27 Million USD | 50.15% |
| 2022 Q1 | 25.49 Million USD | -45.83% |
| 2022 FY | 134.49 Million USD | 1.17% |
| 2021 Q3 | 27.26 Million USD | -2.38% |
| 2021 FY | 132.94 Million USD | 13.62% |
| 2021 Q4 | 47.05 Million USD | 72.6% |
| 2021 Q2 | 27.92 Million USD | -9.02% |
| 2021 Q1 | 30.69 Million USD | -31.06% |
| 2020 Q4 | 44.52 Million USD | 75.39% |
| 2020 FY | 117 Million USD | -14.86% |
| 2020 Q3 | 25.38 Million USD | 3.22% |
| 2020 Q2 | 24.59 Million USD | 9.34% |
| 2020 Q1 | 22.49 Million USD | 0.0% |
| 2019 FY | 137.43 Million USD | -24.9% |
| 2018 FY | 182.98 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -938.856% |
| Prenetics Global Limited | 8.82 Million USD | -1025.462% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -733.28% |
| CareDx, Inc | 178.32 Million USD | 44.272% |
| Exact Sciences Corporation | 1.84 Billion USD | 94.615% |
| Exagen Inc. | 29.45 Million USD | -237.374% |
| Inotiv, Inc. | 165.44 Million USD | 39.933% |
| Guardant Health, Inc. | 336.89 Million USD | 70.502% |
| Biodesix, Inc. | 36.07 Million USD | -175.458% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -7374.776% |
| Precipio, Inc. | 6.01 Million USD | -1551.329% |
| iSpecimen Inc. | 5.1 Million USD | -1845.549% |
| Natera, Inc. | 492.74 Million USD | 79.832% |
| Aspira Women's Health Inc. | 5.26 Million USD | -1788.578% |
| Standard BioTools Inc. | 50.45 Million USD | -96.981% |
| Castle Biosciences, Inc. | 174.8 Million USD | 43.15% |
| Personalis, Inc. | 18.2 Million USD | -445.788% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -654.686% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -1695.938% |
| OpGen, Inc. | -90.69 Thousand USD | 109673.952% |
| T2 Biosystems, Inc. | -8.17 Million USD | 1316.365% |
| Myriad Genetics, Inc. | 476.4 Million USD | 79.14% |
| ICON Public Limited Company | 1.81 Billion USD | 94.523% |
| NeoGenomics, Inc. | 244.6 Million USD | 59.372% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -733.28% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 95.462% |
| RadNet, Inc. | 93 Million USD | -6.857% |
| MDxHealth SA | 43.92 Million USD | -126.222% |
| Psychemedics Corporation | 8.41 Million USD | -1081.231% |
| Illumina, Inc. | 2.74 Billion USD | 96.378% |
| Check-Cap Ltd. | -212 Thousand USD | 46975.943% |
| Twist Bioscience Corporation | 133.34 Million USD | 25.476% |
| DarioHealth Corp. | 5.98 Million USD | -1560.712% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 4.862% |
| Sera Prognostics, Inc. | 96 Thousand USD | -103417.708% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 36177.923% |
| OPKO Health, Inc. | 318.12 Million USD | 68.762% |
| Medpace Holdings, Inc. | 524.5 Million USD | 81.053% |
| Neogen Corporation | 463.9 Million USD | 78.578% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -6870.762% |
| Prenetics Global Limited | 8.82 Million USD | -1025.462% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -19398.724% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -12453.704% |
| Trinity Biotech plc | 19.45 Million USD | -410.936% |
| Neuronetics, Inc. | 51.7 Million USD | -92.2% |
| Sotera Health Company | 577.15 Million USD | 82.782% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -12453.704% |